Management of patients starting treatment with second-generation antipsychotics: insights from a European retrospective real-world analysis
Distinct management behaviours were identified depending on age. A nuanced approach integrating tailored therapeutic strategies is needed to optimise long-term outcomes for patients requiring treatment with SGAs.
Authors
- Riccardo Cipelli
- Giancarlo Cerveri (ORCID: https://orcid.org/0000-0002-3247-7300)
- Claudio Mencacci
- Clara Bagatin (ORCID: https://orcid.org/0000-0002-3706-5823)
- Sabrina Barzaghi
- Agnese Cattaneo (ORCID: https://orcid.org/0009-0009-7489-4987)
- Alessandro Comandini
- Valeria Pegoraro (ORCID: https://orcid.org/0000-0003-2359-6380)
- I. Gabarda Inat
- Alessandro Ruggieri
- Alessandro Lovera
Institutions
- American Society of Addiction Medicine (US)
- ASST Fatebenefratelli Sacco (IT)
- Angelini Pharma (Italy) (IT)
Publication Details
- Journal
- International Journal of Psychiatry in Clinical Practice
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1080/13651501.2025.2564789
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00